Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nazanin Majd, Xiao Wei, Alexis Demopoulos, Adilia Hormigo & Ajai Chari. (2016) Characterization of central nervous system multiple myeloma in the era of novel therapies. Leukemia & Lymphoma 57:7, pages 1709-1713.
Read now
Read now
Muhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, Kong Bing Tan & Wee Joo Chng. (2016) Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence. Cancer Biology & Therapy 17:7, pages 723-726.
Read now
Read now
Xenofon Papanikolaou, Panagiotis Repousis, Tatiana Tzenou, Dimitris Maltezas, Maria Kotsopoulou, Katerina Megalakaki, Maria Angelopoulou, Elektra Dimitrakoloulou, Efstathios Koulieris, Vassiliki Bartzis, Gerasimos Pangalis, Panagiotis Panayotidis & Marie-Christine Kyrtsonis. (2013) Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Leukemia & Lymphoma 54:7, pages 1459-1464.
Read now
Read now
Hai-Fei Chen, Tian-Qin Wu, Zheng-Yang Li, Hong-Shi Shen, Jie-Qing Tang, Wei-Jun Fu, Zhen-Gang Yuan & Jian Hou. (2012) Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance. OncoTargets and Therapy 5, pages 329-334.
Read now
Read now
P Vermeiren, A Vantilborgh & F Offner. (2011) MYELOMA OF THE CENTRAL NERVOUS SYSTEM: REPORT OF A SINGLE CENTER CASE SERIES. Acta Clinica Belgica 66:3, pages 205-208.
Read now
Read now
Articles from other publishers (49)
Vincenzo Sammartano, Alfonso Cerase, Valentina Venanzi, Maria Antonietta Mazzei, Beatrice Esposito Vangone, Francesco Gentili, Ivano Chiarotti, Monica Bocchia & Alessandro Gozzetti. (2022) Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance. Frontiers in Oncology 12.
Crossref
Crossref
Stefan Forster & Ramin Radpour. (2022) Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease. Frontiers in Oncology 12.
Crossref
Crossref
Ting Wang, Ting He, Lie Ma, Yazi Yang, Ru Feng, Yanping Ding, Yueming Shan, Bing Bu, Feifei Qi, Fei Wu, Xin-an Lu & Hui Liu. (2022) Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion. Frontiers in Oncology 12.
Crossref
Crossref
Liang Gao, Junhui Xu, Weiwei Xie, Bingjie Wang, Xinan Cen & Mangju Wang. (2022) Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment 21, pages 153303382211323.
Crossref
Crossref
Ankush Bhatia & Nina A. Paleologos. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
415
431
.
Takeshi Yamashita, Hiroyuki Takamatsu, Koji Kawamura, Kazutaka Sunami, Shotaro Hagiwara, Mitsuhiro Itagaki, Tsutomu Takahashi, Tadakazu Kondo, Takashi Ikeda, Kyoko Watakabe‐Inamoto, Hiroshi Handa, Yoshitaka Imaizumi, Junya Kuroda, Jun Murakami, Yuichi Nakamura, Hideyuki Nakazawa, Shuji Ozaki, Miyuki Okura, Masami Takeuchi, Hirokazu Nagai, Ichiro Hanamura, Shinji Nakao & Shinsuke Iida. (2021) A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival. British Journal of Haematology 195:2, pages 217-229.
Crossref
Crossref
Yi Chen, Yanyan Qiu, Haiying Fu, Jing Li, Lushan Chen, Siqin Liao & Tingbo Liu. (2021) IgD multiple myeloma with central nervous system involvement: A case report and literature review. Molecular and Clinical Oncology 15:4.
Crossref
Crossref
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios‐Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson & Joan Bladé. (2021) Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British Journal of Haematology 194:3, pages 496-507.
Crossref
Crossref
Yasuo Miki, Kosuke Kamata, Yui Akemoto, Fumiyasu Tsushima, Hirotake Sakuraba, Kazufumi Yamagata, Akira Kurose, Shinsaku Fukuda & Koichi Wakabayashi. (2021) Leptomeningeal and intraventricular myelomatosis manifesting an aggressive form of communicating hydrocephalus. Neuropathology 41:3, pages 243-249.
Crossref
Crossref
Shifa Farheen, Abhishek Singh, Poonam Yadav, Preeti Tripathi & Arijit Sen. (2021) Central nervous system involvement: A rare detour for myeloma cells-case report of an usual presentation!. Journal of Applied Hematology 12:4, pages 213.
Crossref
Crossref
Satoko Oka, Kazuo Ono & Masaharu Nohgawa. (2019) Successful treatment with pomalidomide and intrathecal injections for central nervous system plasmacytoma in a patient under haemodialysis. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 221-225.
Crossref
Crossref
Rui Bergantim, Juliana Bastos, Maria José Soares, Bruno Carvalho, Pedro Soares, Cristina Marques, Jennifer Costa, José Eduardo Guimarães & Fernanda Trigo. (2020) Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review. Case Reports in Hematology 2020, pages 1-8.
Crossref
Crossref
Ranjit Nair & Krina Patel. 2020. Oncologic Critical Care. Oncologic Critical Care
1513
1530
.
Miguel Aliste, Alex Larruzea, Vicente Aguadero, Luz Muñoz, María Elena Ramila & Eugenio Berlanga. (2019) Papel central del laboratorio en el diagnóstico de un caso de infiltración de sistema nervioso central por mieloma múltiple refractario. Revista del Laboratorio Clínico 12:4, pages 165-170.
Crossref
Crossref
Sabina Sevcikova, Jiri Minarik, Martin Stork, Tomas Jelinek, Ludek Pour & Roman Hajek. (2019) Extramedullary disease in multiple myeloma – controversies and future directions. Blood Reviews 36, pages 32-39.
Crossref
Crossref
Ranjit Nair & Krina Patel. 2019. Oncologic Critical Care. Oncologic Critical Care
1
18
.
Elochukwu Ibekwe, Neil Horsley, Lan Jiang, Nadine-Stella Achenjang, Azubuogu Anudu, Zeeshan Akhtar, Karina Chornenka, Gregory Monohan & Yevgen Chornenkyy. (2018) Abducens Nerve Palsy as Initial Presentation of Multiple Myeloma and Intracranial Plasmacytoma. Journal of Clinical Medicine 7:9, pages 253.
Crossref
Crossref
Despina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2018) How We Manage Patients with Plasmacytomas. Current Hematologic Malignancy Reports 13:3, pages 227-235.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
585
593
.
Morie A. Gertz, Laura Rosinol & Joan Bladé. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
157
175
.
Mark Podberezin. (2017) Case Study of Intracerebral Recurrence of Plasmablastic Myeloma with Achievement of Complete Response after Treatment with Lenalidomide. Advances in Cytology & Pathology 2:3.
Crossref
Crossref
Parvathi Menon, Winny Varikkat & Steve Vucic. (2017) Isolated nerve plasmacytoma in a patient previously in systemic myeloma remission. Muscle & Nerve 55:6.
Crossref
Crossref
S. Jennane, M. Kerbout, E.M. Mahtat, J. Konopacki & J.V. Malfuson. (2016) Plasmocytomes intraduraux extram?dullaires. Pratique Neurologique - FMC 7:3, pages 209-212.
Crossref
Crossref
Nischala Ammannagari, Kimberly Celotto, Vishala Neppalli, Kelvin Lee & Sarah A. Holstein. (2016) Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies. Clinical Lymphoma Myeloma and Leukemia 16:9, pages e129-e131.
Crossref
Crossref
Artur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, Jacek Czepiel, Alfonso Cerase, Vania Hungria, Edvan Crusoe, Ana Luiza Miranda Silva Dias, Ravi Vij, Mark A. Fiala, Jo Caers, Leo Rasche, Ajay K. Nooka, Sagar Lonial, David H. Vesole, Sandhya Philip, Shane Gangatharan, Agnieszka Druzd-Sitek, Jan Walewski, Alessandro Corso, Federica Cocito, Marie-Christine M. Vekemans, Erden Atilla, Meral Beksac, Xavier Leleu, Julio Davila, Ashraf Badros, Ekta Aneja, Niels Abildgaard, Efstathios Kastritis, Dorotea Fantl, Natalia Schutz, Tomas Pika, Aleksandra Butrym, Magdalena Olszewska-Szopa, Lidia Usnarska-Zubkiewicz, Saad Z. Usmani, Hareth Nahi, Chor S Chim, Chaim Shustik, Krzysztof Madry, Suzanne Lentzsch, Alina Swiderska, Grzegorz Helbig, Renata Guzicka-Kazimierczak, Nikoletta Lendvai, Anders Waage, Kristian T. Andersen, Hirokazu Murakami, Sonja Zweegman & Jorge J. Castillo. (2016) Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. American Journal of Hematology 91:6, pages 575-580.
Crossref
Crossref
Melissa Gaik-Ming Ooi, Sanjay de Mel & Wee Joo Chng. (2016) Risk Stratification in Multiple Myeloma. Current Hematologic Malignancy Reports 11:2, pages 137-147.
Crossref
Crossref
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Sossana Delimpasis, Argiris S. Symeonidis, Panagiotis Repousis, Marie-Christine Kyrtsonis, Chrysa Vadikolia, Eurydiki Michalis, Genovefa Polychronidou, Michael Michael, Sofia Papadaki, Maria Papathanasiou, Kyriaki Kokoviadou, Anna Kioumi, Eythimia Vlachaki, Christina Hadjiaggelidou, Alexandra Kouraklis, Ioannis Patsias, Maria Gavriatopoulou, Maria Kotsopoulou, Evgenia Verrou, Vasiliki Gastari, Dimitrios Christoulas, Evlambia Giannopoulou, Anastasia Pouli, Pavlina Konstantinidou, Achilles Anagnostopoulos & Meletios-Athanasios Dimopoulos. (2015) Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience. Annals of Hematology 94:12, pages 2033-2042.
Crossref
Crossref
Jiajia Zhang & Yuping Zhong. (2015) Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal. Hematological Oncology 33:2, pages 75-79.
Crossref
Crossref
Artur Jurczyszyn, Magdalena Olszewska-Szopa, Szymon Fornagiel & Aleksander Skotnicki. (2015) Zajęcie ośrodkowego układu nerwowego w przebiegu szpiczaka plazmocytowego – opis przypadku i przegląd literatury. Acta Haematologica Polonica 46:3, pages 242-247.
Crossref
Crossref
Katya A. Shpilberg, Steven J. Esses, Mary E. Fowkes, Ajai Chari, Michael Sacher & Thomas P. Naidich. (2015) Imaging of extraosseous intracranial and intraspinal multiple myeloma, including central nervous system involvement. Clinical Imaging 39:2, pages 213-219.
Crossref
Crossref
Hirono Iriuchishima, Takayuki Saitoh, Hiroshi Handa, Atsushi Isoda, Morio Matsumoto, Morio Sawamura, Atsushi Iwasaki, Chiaki Ushie, Hikaru Hattori, Yoshiko Sasaki, Takeki Mitsui, Akihiko Yokohama, Norifumi Tsukamoto, Hirokazu Murakami & Yoshihisa Nojima. (2015) A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents. European Journal of Haematology 94:2, pages 145-151.
Crossref
Crossref
Xiaoyan Qu, Lijuan Chen, Hairong Qiu, Hua Lu, Hanxin Wu, Hongxia Qiu, Peng Liu, Rui Guo & Jianyong Li. (2015) Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Chafic Y. Karam & Michelle L. Mauermann. 2014. Multiple Myeloma. Multiple Myeloma
245
255
.
Joan Bladé & Laura Rosiñol. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
665
680
.
Shane A Gangatharan, Dennis A Carney, H Miles Prince, Max M Wolf, E Henry Januszewicz, David S Ritchie & Simon J Harrison. (2011) Emergence of central nervous system myeloma in the era of novel agents. Hematological Oncology 30:4, pages 170-174.
Crossref
Crossref
Hanny Haaxma-Reiche. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
711
729
.
Jan Drappatz & Kurt A. Jaeckle. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
299
312
.
Joan BladéCarlos Fernández de LarreaLaura RosiñolMaría Teresa CibeiraRaquel JiménezRay Powles. (2011) Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach. Journal of Clinical Oncology 29:28, pages 3805-3812.
Crossref
Crossref
Ba D. Nguyen, Panol C. Ram & Michael C. Roarke. (2010) PET/CT and MR Imaging of Central Nervous System Myelomatosis. Clinical Nuclear Medicine 35:12, pages 953-955.
Crossref
Crossref
C. S. Chim, A. K. W. Lie, E. Y. T. Chan, Y. Y. Leung, S. C. W. Cheung, S. Y. T. Chan, Raymond Liang & Y. L. Kwong. (2010) A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. Annals of Hematology 89:10, pages 1019-1027.
Crossref
Crossref
R. Velasco, J. Petit, R. Llatjós, A. Juan & J. Bruna. (2010) Can leptomeningeal myelomatosis be predicted in patients with IgD multiple myeloma?. Journal of Clinical Neuroscience 17:8, pages 1071-1072.
Crossref
Crossref
Abdul Rahman Mourad, Mohamed A. Kharfan-Dabaja, Kaaron Benson, Lynn C. Moscinski & Rachid C. Baz. (2010) Leptomeningeal Myeloma As the Sole Manifestation of Relapse: An Unusual Presentation. The American Journal of the Medical Sciences 339:1, pages 81-82.
Crossref
Crossref
Julie M. Wu, Matthew F. Georgy, Frances H. Burroughs, Edward G. Weir, Dorothy L. Rosenthal & Syed Z. Ali. (2009) Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: Is accurate cytopathologic diagnosis possible based on morphology alone?. Diagnostic Cytopathology 37:11, pages 820-824.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2009. Treatment of Multiple Myeloma and Related Disorders. Treatment of Multiple Myeloma and Related Disorders
76
85
.
M C Minnema, N W C J van de Donk, S Zweegman, U Hegenbart, S Schonland, R Raymakers, J M J M Zijlmans, M J Kersten, G M J Bos & H M Lokhorst. (2008) Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome. Bone Marrow Transplantation 41:9, pages 779-784.
Crossref
Crossref
Joan Blad?Laura Rosi?ol. (2007) Complications of Multiple Myeloma. Hematology/Oncology Clinics of North America 21:6, pages 1231-1246.
Crossref
Crossref
Marianna Colagrande, Mauro Di Ianni, Raffaella Ciurnelli, Massimo Gallucci, Guglielmo Mariani & Antonio Tabilio. (2007) Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis. British Journal of Haematology 138:6, pages 812-813.
Crossref
Crossref
Aurelia Wavre, Audrey S. Baur, Michael Betz, Dominique Mühlematter, Martine Jotterand, Khalil Zaman & Nicolas Ketterer. (2007) Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma. Neuro-Oncology 9:3, pages 370-372.
Crossref
Crossref
Andrea Wong, Noorainun Md Yusof, Sing-Huang Tan & Wee J Chng. (2005) Multiple Myeloma Presenting with Complex Cranial Nerve Palsies. Journal of Neuro-Oncology 74:2, pages 217-218.
Crossref
Crossref